Paxlovid pill test halted before it began
NCT ID NCT06397144
Summary
This study aimed to see if a new, combined tablet form of the COVID-19 antiviral Paxlovid (nirmatrelvir/ritonavir) works the same way in the body as the original separate pills. It planned to test this in a small group of healthy adults by measuring drug levels in their blood. The study was withdrawn by the sponsor before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.